[HTML][HTML] Inflammatory bowel disease and cancer: The role of inflammation, immunosuppression, and cancer treatment
JE Axelrad, S Lichtiger, V Yajnik - World journal of …, 2016 - ncbi.nlm.nih.gov
In patients with inflammatory bowel disease (IBD), chronic inflammation is a major risk factor
for the development of gastrointestinal malignancies. The pathogenesis of colitis-associated …
for the development of gastrointestinal malignancies. The pathogenesis of colitis-associated …
Cancers complicating inflammatory bowel disease
L Beaugerie, SH Itzkowitz - New England Journal of Medicine, 2015 - Mass Medical Soc
Cancers Complicating Inflammatory Bowel Disease | New England Journal of Medicine Skip to
main content The New England Journal of Medicine homepage Advanced Search SEARCH …
main content The New England Journal of Medicine homepage Advanced Search SEARCH …
European evidence-based consensus: inflammatory bowel disease and malignancies
V Annese, L Beaugerie, L Egan… - Journal of Crohn's …, 2015 - academic.oup.com
The global prevalence of cancer is increasing, largely as more patients are living into old
age. Therefore, gastroenterologists caring for patients with inflammatory bowel disease [IBD] …
age. Therefore, gastroenterologists caring for patients with inflammatory bowel disease [IBD] …
Progress and problems in understanding and managing primary Epstein-Barr virus infections
OA Odumade, KA Hogquist… - Clinical microbiology …, 2011 - Am Soc Microbiol
Epstein-Barr virus (EBV) is a gammaherpesvirus that infects a large fraction of the human
population. Primary infection is often asymptomatic but results in lifelong infection, which is …
population. Primary infection is often asymptomatic but results in lifelong infection, which is …
Global and regional incidence, mortality and disability-adjusted life-years for Epstein-Barr virus-attributable malignancies, 1990–2017
Objective To determine the global and regional burden of Epstein-Barr virus (EBV)-attributed
malignancies. Design An international comparative study based on the Global Burden of …
malignancies. Design An international comparative study based on the Global Burden of …
The rising challenge of non–AIDS-defining cancers in HIV-infected patients
JF Deeken, A Tjen-A-Looi, MA Rudek… - Clinical infectious …, 2012 - academic.oup.com
Since the advent of HAART, patients with HIV infection have seen a significant improvement
in their morbidity, mortality, and life expectancy. The incidence of AIDS-defining illnesses …
in their morbidity, mortality, and life expectancy. The incidence of AIDS-defining illnesses …
Constitutive interferon-inducible protein 16-inflammasome activation during Epstein-Barr virus latency I, II, and III in B and epithelial cells
MA Ansari, VV Singh, S Dutta, MV Veettil… - Journal of …, 2013 - Am Soc Microbiol
ABSTRACT Epstein-Barr virus (EBV), etiologically linked with human B-cell malignancies
and nasopharyngeal carcinoma (NPC), establishes three types of latency that facilitate its …
and nasopharyngeal carcinoma (NPC), establishes three types of latency that facilitate its …
Herpesviruses: harmonious pathogens but relevant cofactors in other diseases?
Most vertebrates are infected with one or more herpesviruses and remain so for the rest of
their lives. The relationship of immunocompetent healthy host with herpesviruses may …
their lives. The relationship of immunocompetent healthy host with herpesviruses may …
Cancer recurrence following immune-suppressive therapies in patients with immune-mediated diseases: a systematic review and meta-analysis
Background & Aims Physicians frequently encounter patients with immune-mediated
diseases and a history of malignancy. There are limited data on the safety of …
diseases and a history of malignancy. There are limited data on the safety of …
Nasopharyngeal carcinoma: the next challenges
Nasopharyngeal carcinoma (NPC) differs from other head and neck cancers in its aetiology,
epidemiology and potential therapeutic options. Despite cure for the majority of the patients …
epidemiology and potential therapeutic options. Despite cure for the majority of the patients …